Order results by:
| Issue | Title | |
| Vol 13, No 4 (2017) | FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION | Abstract similar documents |
| V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva | ||
| "... regions in viral hepatic cirrhosis A, B, C classes according to Child-Pugh with different serum levels ..." | ||
| Vol 15, No 2 (2019) | Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... of antiviral therapy on these parameters in patients with viral liver cirrhosis (VLC). Material and methods ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... and the liver in patients with viral cirrhosis. Material and methods. In 75 patients with chronic viral ..." | ||
| Vol 12, No 6 (2016) | POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES | Abstract similar documents |
| V. E Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva | ||
| "... cirrhosis of viral etiology classes A, B, C (ChildPugh) with different levels of serum interleukins ..." | ||
| Vol 13, No 3 (2017) | ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... cirrhosis (LC) and its impact on some indicators of portal hemodynamics, and echocardiographic parameters ..." | ||
| Vol 14, No 3 (2018) | FEATURES OF HEART LESIONS IN PATIENTS WITH VIRAL LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin | ||
| "... of antiviral therapy on certain cardiohemodynamic parameters in patients with viral liver cirrhosis (VLC ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... in patients with chronic viral hepatitis (CVH) and viral liver cirrhosis (VLC). Material and methods. Doppler ..." | ||
| Vol 14, No 4 (2018) | Some Morpho-Functional Changes of the Left Heart in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M V. Chistyakova, A. V. Govorin, N. N. Kushnarenko | ||
| "... Цель. Изучить влияние вирусного цирроза печени (ВЦП) на некоторые кардиогемодинамические параметры ..." | ||
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| "... in congestive heart failure, nephrotic syndrome, and portal cirrhosis is considered in the article. Development ..." | ||
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... Рассматривается проблема неалкогольной жировой болезни печени (НАЖБП), являющейся независимым ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... flow in the hepatic artery in comparison with the control (p<0.001). Conclusion. In patients with CVH ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... смертности больных с НАЖБП первое место занимает не патология печени (цирроз и гепатоцеллюлярная карцинома ..." | ||
| Vol 19, No 6 (2023) | Platelet phenotypes and practical aspects of platelet function testing in cardiology | Abstract similar documents |
| Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. A. Boldyreva, D. P. Lazutova, I. A. Meray, M. A. Panteleev | ||
| "... .), and acquired (symptomatic) platelet disorders (in hemoblastoses, uremia, liver cirrhosis, etc.), as well ..." | ||
| Vol 12, No 4 (2016) | Organoprotective effects of serelaxin in patients with severe decompensated heart failure | Abstract similar documents |
| Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai | ||
| "... decompensated heart failure with cardio-hepatic syndrome led to significant regression of systemic congestion ..." | ||
| Vol 5, No 2 (2009) | NEW PATHOGENIC MECHANISMS OF THE CHRONIC PERICARDITIS | Abstract similar documents |
| V. V. Kochmasheva, E. D. Rozhdestvenskaya, E. S. Belikov, M. A. Dergunova, M. V. Arhipov | ||
| Vol 19, No 1 (2023) | Inflammatory Activity in Patients with Obstructive and Non-obstructive Coronary Artery Disease | Abstract similar documents |
| N. N. Pakhtusov, A. O. Yusupova, A. S. Lishuta, O. A. Slepova, E. V. Privalova, Yu. N. Belenkov | ||
| "... ) CAD. The levels of interleukin-1β (IL-1β) and interleukin 6 (IL-6) were measured in plasma using ..." | ||
| Vol 21, No 1 (2025) | Cytokine profile of surgical patients with infective endocarditis | Abstract similar documents |
| E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava | ||
| Vol 13, No 5 (2017) | NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE | Abstract similar documents |
| O. M. Drapkina, A. A. Yafarova | ||
| "... Неалкогольная жировая болезнь печени (НАЖБП) – самое распространенное заболевание печени в мире ..." | ||
| Vol 4, No 4 (2008) | CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES | Abstract similar documents |
| M. N. Mamedov, O. M. Drapkina | ||
| "... встречаются и хронические диффузные заболевания печени (в 40% случаев). В статье на примере конкретного ..." | ||
| Vol 14, No 5 (2018) | Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case | Abstract similar documents |
| M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov | ||
| "... formation. A potential contribution of hepatic dysfunction to reduction in antiaggregant effect of P2Y12 ..." | ||
| Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
| A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
| "... with AF without impaired renal and hepatic function. Due to the increase in the residual plasma ..." | ||
| Vol 3, No 4 (2007) | THE PECULIARITIES OF CEREBRAL BLOOD FLOW IN PATIENTS WITH CHRONIC HEPATITIS | Abstract similar documents |
| V. E. Kulikov, B. B. Fishman, A. V. Volkov, G. S. Malyutin, G. I. Shvartsman | ||
| Vol 12, No 6 (2016) | CURRENT METHODS OF ENDOTHELIAL DYSFUNCTION ASSESSMENT AND THEIR POSSIBLE USE IN THE PRACTICAL MEDICINE | Abstract similar documents |
| A. V. Shabrov, A. G. Apresyan, A. L. Dobkes, S. U. Ermolov, T. V. Ermolova, S. G. Manasyan, S. V. Serdyukov | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... acids pathways. TMAO (the hepatic oxidation product of the microbial metabolite of trimethylamine ..." | ||
| Vol 11, No 3 (2015) | IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Goncharova, E. V. Radaeva | ||
| "... specific treatment. Reduction in hepatic arterial and portal blood flow speed and a total number of heart ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... заболеваниями и сопутствующими хроническими болезнями печени. Анализ отечественных публикаций последних лет ..." | ||
| Vol 12, No 3 (2016) | Проблема назначения статинов больным с сердечно-сосудистыми заболеваниями и сопутствующими болезнями печени. Что препятствует преодолению статинофобии? | Abstract similar documents |
| "... заболеваниями и сопутствующими хроническими болезнями печени. Анализ отечественных публикаций последних лет ..." | ||
| Vol 19, No 4 (2023) | Bedside ultrasound assessment of venous congestion by VExUS protocol in heart failure: clinical associations and prognostic value | Abstract similar documents |
| Zh. D. Kobalava, R. Sh. Aslanova, A. F. Safarova, M. V. Vatsik-Gorodetskaya | ||
| "... severity was determined on the deviation of Doppler curves of hepatic, portal and renal veins. If the IVC ..." | ||
| Vol 5, No 6 (2009) | STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? | Abstract similar documents |
| I. N. Grigorieva, Y. M. Pozdnyakov | ||
| "... ) желчнокаменной болезни (ЖКБ), неалкогольной жировой болезни печени (НАЖБП), неалкогольного стеатогепатита (НАСГ ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... риска с неалкогольной жировой болезнью печени (НАЖБП) и другими заболеваниями гепатобилиарной системы ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... печени у больных с сердечно-сосудистыми заболеваниями (ССЗ) и высоким риском сердечно-сосудистых ..." | ||
| Vol 11, No 2 (2015) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? | Abstract similar documents |
| S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov | ||
| "... -сосудистыми заболеваниями (ССЗ) и сопутствующими хрониче-скими заболеваниями печени. Материал и методы ..." | ||
| Vol 9, No 2 (2013) | STATIN SAFETY REVISITED DATA | Abstract similar documents |
| O. M. Drapkina | ||
| "... Рассматриваются вопросы применения статинов при заболеваниях печени. Приводятся данные клинических ..." | ||
| Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
| A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
| "... различных проявлений повреждений печени при применении лекарственных средств из группы новых оральных ..." | ||
| Vol 13, No 1 (2017) | Рекомендации по совместному назначению статинов и урсодезоксихолевой кислоты пациентам с высоким риском сердечно-сосудистых осложнений и сопутствующей неалкогольной жировой болезнью печени: проблемы практического применения | Abstract similar documents |
| "... риска с неалкогольной жировой болезнью печени (НАЖБП) и другими заболеваниями гепатобилиарной системы ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... печени и/или желчевыводящих путей всем пациентам был рекомендован прием УДХК. Часть пациентов четко ..." | ||
| Vol 18, No 4 (2022) | Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels | Abstract PDF (Eng) similar documents |
| O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov | ||
| "... ) results, lung, renal and hepatic dysfunction. The association between different doses of ACT and treatment ..." | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... the following: the levels of total leukocytes, interleukin-8, interleukin-10, C-reactive protein, fibrinogen ..." | ||
| Vol 3, No 2 (2007) | IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov | ||
| "... were used to verify of IHD. Levels of С-reactive protein (CRP), pro-inflammatory cytokines: interleukin ..." | ||
| Vol 7, No 4 (2011) | USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING | Abstract similar documents |
| A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel | ||
| "... of Chebotarev D.F ., determination of p53 protein and interleukin-8, 10, 18 concentrations by solid phase enzyme ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... хронической обструктивной болезнью легких, пожилые пациенты, сопутствующие заболевания печени). ..." | ||
| Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
| O. V. Andropova, V. N. Anokhin | ||
| "... and interleukin-6. There were significant correlations between DAS severity, lipid metabolism disturbances ..." | ||
| Vol 10, No 5 (2014) | THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, A. N. Zakirova | ||
| "... with proinflammatory cytokines – interleukin-1β, interleukin-6, tumor necrosis factor-alpha (TGF-α) (r=-0.39; -0.54; -0 ..." | ||
| Vol 16, No 5 (2020) | COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II) | Abstract similar documents |
| O. V. Blagova, N. V. Varionchik, M. M. Beraia, V. A. Zaidenov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup | ||
| "... with levofloxacin, an interleukin-17 inhibitor (netakimab) were performed. The severity of pneumonia and respiratory ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... . Examination of patients with STEMI included the assessment of plasma lipid profile, blood levels of hepatic ..." | ||
| Vol 12, No 3 (2016) | MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES | Abstract PDF (Eng) similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| "... печени и онкологическими процессами. ..." | ||
| Vol 6, No 1 (2010) | SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT | Abstract similar documents |
| N. A. Jaiani | ||
| "... хронической обструктивной болезнью легких, пожилые пациенты, сопутствующие заболевания печени). Кроме того ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova | ||
| "... , inhibition of pro-inflammatory cytokines [tumor necrosis factor alpha (TNF-α), interleukins (IL-1β IL-6 ..." | ||
| Vol 3, No 5 (2007) | IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| R. G. Oganov, N. E. Zakirova, A. N. Zakirova, G. M. Salakhova, M. R. Plotnikova | ||
| "... (interleukins [IL-1β, IL-6], tumor necrosis factor [TNF-α]) and anti-inflammatory (IL-4, IL-10) cytokines we ..." | ||
| Vol 4, No 2 (2008) | INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE | Abstract similar documents |
| O. P. Dudarenko, E. L. Shkol’nik, , , | ||
| "... factor-α, interleukin-6) and neuronhormone levels was found in patients with CHF of I-II class ..." | ||
| Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
| O. M. Drapkina | ||
| "... of lipids, electrolytes, creatinine, uric acid blood concentrations, and hepatic transaminase activity ..." | ||
| Vol 1, No 3 (2005) | EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim | ||
| "... mg/dl). of Treatment safety was assessed on the basis of clinical data, hepatic enzymes activity ..." | ||
| Vol 18, No 5 (2022) | Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age | Abstract similar documents |
| N. I. Solomakhina, A. S. Lishuta, A. V. Dementieva | ||
| "... , transferrin, erythropoietin, hepcidin), inflammation [C-reactive protein (CRP), interleukin-6 (IL-6)], as well ..." | ||
| Vol 8, No 5 (2012) | INFLAMMATORY REACTIONS IN EXPERIMENTAL MYOCARDIAL DAMAGE | Abstract similar documents |
| L. D. Khidirova, N. N. Mayanskaya | ||
| "... (from 5.5±0.03 to 12.6±1.23 pg/ml) and interleukin-1β (from 6.0±0.18 to 11.1±0.78 pg/ml). Conclusion ..." | ||
| Vol 15, No 6 (2019) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs | Abstract similar documents |
| D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova | ||
| "... therapy has been shown. Inhibitors of interleukin (IL) -1, inhibitors of IL-6, inhibitors of T-cell co ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... ), alanine aminotransaminase (ALT), creatine kinase (CK), C-reactive protein (CRP), interleukin-6 (IL-6 ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... was 39.3% higher (p=0.001), interleukin-10 – 20.2% higher (p=0.01), superoxide dismutase – 78.9% higher ..." | ||
| Vol 8, No 1 (2012) | URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL | similar documents |
| S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker | ||
| "... заболеваний печени с холестазом, обладает противовоспалительным и цитопротекторными свойствами и может ..." | ||
| Vol 15, No 5 (2019) | Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
| "... повреждение печени и ряд других редких побочных реакций. В статье представлен случай ривароксабан ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... .5 mg/ml) and proinflammatory factors blood levels (C-reactive protein [CRP], interleukin 6 [IL-6]) were ..." | ||
| Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
| A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
| "... of the therapy was evaluated by clinical, instrumental and laboratory parameters. Dynamics of interleukin (IL)-1β ..." | ||
| Vol 9, No 3 (2013) | INFLUENCE OF ACARBOSE ON POSTPRANDIAL DYSMETABOLISM: RESULTS OF AN OPEN-LABEL RANDOMIZED STUDY | Abstract PDF (Eng) similar documents |
| A. Ya. Cherniak, I. M. Petrov, I. V. Medvedeva | ||
| "... as concentrations of C-reactive protein (CRP) – by 49.7%, tumor necrose factor alpha – by 20.8%, and interleukin-6 ..." | ||
| Vol 8, No 4 (2012) | INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION | Abstract similar documents |
| T. V. Martynyuk, S. N. Nakonechnikov, V. P. Masenko, I. E. Chazova | ||
| "... ), interleukins (IL), interferon-γ (INFγ), tumor necrosis factor a (TNFa), macrophage inflammatory protein a (MIP1 ..." | ||
| Vol 14, No 2 (2018) | NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY | Abstract similar documents |
| S. G. Shulkina, Е. N. Smirnova | ||
| "... , albuminuria, NGAL (neutrophil gelatinase associated lipocalin) and interleukin 18 (IL-18) in the urine ..." | ||
| Vol 20, No 4 (2024) | Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis | Abstract similar documents |
| S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... of low-grade inflammation high-sensitivity C-reactive protein and interleukin-6 did not differ between ..." | ||
| Vol 15, No 5 (2019) | Clinical Case: Atypical Warfarin-induced Skin Necrosis | Abstract similar documents |
| T. V. Kondratieva, L. V. Popova, S. S. Karachev, A. S. Lishuta, M. Z. Kanevskaya | ||
| "... возникновения ВИНК (несоблюдение режима приема антивитаминов К или повторная терапия, дисфункция печени и ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... . Они, в основном, включают повреждение печени, почек и ряда других редких побочных реакций. Обнаружение ..." | ||
| Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... /сут. Каждые 4 нед оценивали липидный спектр, активность ферментов печени, креатинфосфокиназы ..." | ||
| Vol 16, No 1 (2020) | Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants | Abstract similar documents |
| A. N. Meshkov, A. I. Ershova, S. A. Shalnova, A. S. Alieva, S. S. Bazhan, O. L. Barbarash, D. Y. Bogdanov, I. A. Viktorova, Yu. I. Grinshtein, D. V. Duplyakov, O. N. Kalachikova, A. V. Kontsevaya, R. A. Libis, I. V. Medvedeva, V. A. Nevzorova, N. N. Prishchepa, O. P. Rotar, V. N. Serebryakova, I. A. Trubacheva, T. M. Chernykh, E. A. Shutemova, O. M. Drapkina, S. A. Boytsov | ||
| "... определения уровней ферментов печени, тиреотропного гормона) и генетического тестирования. Диагноз СГХС ..." | ||
| 1 - 69 of 69 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
